Afatinib in chemotherapy pre-treated EGFR mutation-positive NSCLC
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2018-11, Vol.29, p.ix146-ix146 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | ix146 |
|---|---|
| container_issue | |
| container_start_page | ix146 |
| container_title | Annals of oncology |
| container_volume | 29 |
| creator | Thongprasert, S. Geater, S.L. Clement, D. Abdelaziz, A. Reyes-Igama, J. Jovanovic, D. Alexandru, A. Schenker, M. Sriuranpong, V. Serwatowski, P. Suresh, S. Cseh, A. Gaafar, R. |
| description | |
| doi_str_mv | 10.1093/annonc/mdy446.008 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdy446_008</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0923753419434418</els_id><sourcerecordid>32177847</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2308-3bfc4c87ea13c1e4dfb15d86a4996e29956e67e9c29907f1da348cad7261e9f03</originalsourceid><addsrcrecordid>eNp9kMtOwzAQRS0EoqXwAWxQfiCtHTt-iFUVtQUpAonH2nLssWpEHnLSSv17ggIsWc0s7rmaOQjdErwkWNGVaZq2savanRjjS4zlGZqTnKtUYkbO0RyrjKYip2yGrvr-A2PMVaYu0YxmRAjJxByt194MoQlVEprE7qFuhz1E052SLkI6RDADuGSz274k9WEYo22Tdm0fhnCE5Om1KItrdOHNZw83P3OB3rebt-IhLZ93j8W6TG1GsUxp5S2zUoAh1BJgzlckd5IbphSHTKmcAxeg7Lhi4YkzlElrnMg4AeUxXSAy9drY9n0Er7sYahNPmmD9rUNPOvSkQ486RuZuYrpDVYP7I37_HwP3UwDGy48Bou5tgMaCCxHsoF0b_qn_AjuScnM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Afatinib in chemotherapy pre-treated EGFR mutation-positive NSCLC</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Thongprasert, S. ; Geater, S.L. ; Clement, D. ; Abdelaziz, A. ; Reyes-Igama, J. ; Jovanovic, D. ; Alexandru, A. ; Schenker, M. ; Sriuranpong, V. ; Serwatowski, P. ; Suresh, S. ; Cseh, A. ; Gaafar, R.</creator><creatorcontrib>Thongprasert, S. ; Geater, S.L. ; Clement, D. ; Abdelaziz, A. ; Reyes-Igama, J. ; Jovanovic, D. ; Alexandru, A. ; Schenker, M. ; Sriuranpong, V. ; Serwatowski, P. ; Suresh, S. ; Cseh, A. ; Gaafar, R.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdy446.008</identifier><identifier>PMID: 32177847</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><ispartof>Annals of oncology, 2018-11, Vol.29, p.ix146-ix146</ispartof><rights>2018 THE AUTHORS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32177847$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Thongprasert, S.</creatorcontrib><creatorcontrib>Geater, S.L.</creatorcontrib><creatorcontrib>Clement, D.</creatorcontrib><creatorcontrib>Abdelaziz, A.</creatorcontrib><creatorcontrib>Reyes-Igama, J.</creatorcontrib><creatorcontrib>Jovanovic, D.</creatorcontrib><creatorcontrib>Alexandru, A.</creatorcontrib><creatorcontrib>Schenker, M.</creatorcontrib><creatorcontrib>Sriuranpong, V.</creatorcontrib><creatorcontrib>Serwatowski, P.</creatorcontrib><creatorcontrib>Suresh, S.</creatorcontrib><creatorcontrib>Cseh, A.</creatorcontrib><creatorcontrib>Gaafar, R.</creatorcontrib><title>Afatinib in chemotherapy pre-treated EGFR mutation-positive NSCLC</title><title>Annals of oncology</title><addtitle>Ann Oncol</addtitle><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kMtOwzAQRS0EoqXwAWxQfiCtHTt-iFUVtQUpAonH2nLssWpEHnLSSv17ggIsWc0s7rmaOQjdErwkWNGVaZq2savanRjjS4zlGZqTnKtUYkbO0RyrjKYip2yGrvr-A2PMVaYu0YxmRAjJxByt194MoQlVEprE7qFuhz1E052SLkI6RDADuGSz274k9WEYo22Tdm0fhnCE5Om1KItrdOHNZw83P3OB3rebt-IhLZ93j8W6TG1GsUxp5S2zUoAh1BJgzlckd5IbphSHTKmcAxeg7Lhi4YkzlElrnMg4AeUxXSAy9drY9n0Er7sYahNPmmD9rUNPOvSkQ486RuZuYrpDVYP7I37_HwP3UwDGy48Bou5tgMaCCxHsoF0b_qn_AjuScnM</recordid><startdate>201811</startdate><enddate>201811</enddate><creator>Thongprasert, S.</creator><creator>Geater, S.L.</creator><creator>Clement, D.</creator><creator>Abdelaziz, A.</creator><creator>Reyes-Igama, J.</creator><creator>Jovanovic, D.</creator><creator>Alexandru, A.</creator><creator>Schenker, M.</creator><creator>Sriuranpong, V.</creator><creator>Serwatowski, P.</creator><creator>Suresh, S.</creator><creator>Cseh, A.</creator><creator>Gaafar, R.</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201811</creationdate><title>Afatinib in chemotherapy pre-treated EGFR mutation-positive NSCLC</title><author>Thongprasert, S. ; Geater, S.L. ; Clement, D. ; Abdelaziz, A. ; Reyes-Igama, J. ; Jovanovic, D. ; Alexandru, A. ; Schenker, M. ; Sriuranpong, V. ; Serwatowski, P. ; Suresh, S. ; Cseh, A. ; Gaafar, R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2308-3bfc4c87ea13c1e4dfb15d86a4996e29956e67e9c29907f1da348cad7261e9f03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Thongprasert, S.</creatorcontrib><creatorcontrib>Geater, S.L.</creatorcontrib><creatorcontrib>Clement, D.</creatorcontrib><creatorcontrib>Abdelaziz, A.</creatorcontrib><creatorcontrib>Reyes-Igama, J.</creatorcontrib><creatorcontrib>Jovanovic, D.</creatorcontrib><creatorcontrib>Alexandru, A.</creatorcontrib><creatorcontrib>Schenker, M.</creatorcontrib><creatorcontrib>Sriuranpong, V.</creatorcontrib><creatorcontrib>Serwatowski, P.</creatorcontrib><creatorcontrib>Suresh, S.</creatorcontrib><creatorcontrib>Cseh, A.</creatorcontrib><creatorcontrib>Gaafar, R.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Thongprasert, S.</au><au>Geater, S.L.</au><au>Clement, D.</au><au>Abdelaziz, A.</au><au>Reyes-Igama, J.</au><au>Jovanovic, D.</au><au>Alexandru, A.</au><au>Schenker, M.</au><au>Sriuranpong, V.</au><au>Serwatowski, P.</au><au>Suresh, S.</au><au>Cseh, A.</au><au>Gaafar, R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Afatinib in chemotherapy pre-treated EGFR mutation-positive NSCLC</atitle><jtitle>Annals of oncology</jtitle><addtitle>Ann Oncol</addtitle><date>2018-11</date><risdate>2018</risdate><volume>29</volume><spage>ix146</spage><epage>ix146</epage><pages>ix146-ix146</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>32177847</pmid><doi>10.1093/annonc/mdy446.008</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2018-11, Vol.29, p.ix146-ix146 |
| issn | 0923-7534 1569-8041 |
| language | eng |
| recordid | cdi_crossref_primary_10_1093_annonc_mdy446_008 |
| source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| title | Afatinib in chemotherapy pre-treated EGFR mutation-positive NSCLC |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T20%3A07%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Afatinib%20in%20chemotherapy%20pre-treated%20EGFR%20mutation-positive%20NSCLC&rft.jtitle=Annals%20of%20oncology&rft.au=Thongprasert,%20S.&rft.date=2018-11&rft.volume=29&rft.spage=ix146&rft.epage=ix146&rft.pages=ix146-ix146&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdy446.008&rft_dat=%3Cpubmed_cross%3E32177847%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/32177847&rft_els_id=S0923753419434418&rfr_iscdi=true |